Urcosimod in Phase 2 clinical trial for Neuropathic Corneal Pain shown to have Long-Term StabilityUrcosimod stable in single-use ampoules for ...

Urcosimod (formerly known as OK-101) has been shown to be stable for over 2 and a half years in single-use ampoules used for ...

Urcosimod is presently in a Phase 2b, randomized, placebo-controlled, double-masked, 48-patient clinical trial to treat NCP patients. “Success for a drug in clinical development is not just ...

OKYO Pharma (OKYO) announced that the Company has established that urcosimod has been shown to be stable for over two and a half years in ...